Jul 1, 2026 07:05AM
Jun 24, 2026 07:30AM
Jun 24, 2026 07:30AM
Jun 16, 2026 07:31AM
Jun 16, 2026 07:30AM
Jun 1, 2026 07:30AM
May 21, 2026 07:30AM Cognition Therapeutics meets with FDA on DLB psychosis drug
May 21, 2026 07:30AM
May 14, 2026 07:31AM
May 14, 2026 07:30AM
May 7, 2026 04:15PM
Mar 31, 2026 04:31PM
Mar 31, 2026 04:30PM
Mar 26, 2026 07:31AM Cognition Therapeutics reports 2025 loss of $23.5 million
Mar 26, 2026 07:30AM
Mar 17, 2026 07:31AM
Mar 17, 2026 07:30AM
Mar 2, 2026 07:31AM
Mar 2, 2026 07:30AM
Feb 5, 2026 07:31AM
Feb 5, 2026 07:30AM Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Jan 27, 2026 07:31AM
Jan 27, 2026 07:30AM
Jan 6, 2026 07:30AM
Jan 6, 2026 07:30AM
Dec 3, 2025 07:30AM
Dec 3, 2025 07:30AM
Dec 1, 2025 07:31AM Cognition Therapeutics presents Phase 3 plan for alzheimer's drug
Dec 1, 2025 07:30AM
Nov 6, 2025 07:30AM
Aug 12, 2025 04:00PM
Aug 12, 2025 04:00PM
Aug 7, 2025 04:00PM
Jul 29, 2025 07:30AM
Jul 21, 2025 07:31AM Cognition Therapeutics publishes zervimesine study data
Jul 21, 2025 07:30AM
Jul 16, 2025 07:31AM
Jul 16, 2025 07:30AM
Jul 14, 2025 07:07AM
Jul 10, 2025 07:31AM
Jul 10, 2025 07:30AM
Jun 26, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
Jun 25, 2025 07:30AM
May 7, 2025 07:30AM
Mar 24, 2025 06:42AM
Mar 20, 2025 07:00AM
Feb 26, 2025 07:00AM
Feb 26, 2025 07:00AM
Jan 8, 2025 04:14PM Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences
Dec 18, 2024 07:23AM

325,143 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All